March 25 (Reuters) - Nkgen Biotech Inc :
* NKGEN BIOTECH PRESENTS ADDITIONAL PHASE 1 CLINICAL TRIAL DATA IN ALZHEIMER’S DISEASE AT THE TAU2024 GLOBAL CONFERENCE
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
March 25 (Reuters) - Nkgen Biotech Inc :
* NKGEN BIOTECH PRESENTS ADDITIONAL PHASE 1 CLINICAL TRIAL DATA IN ALZHEIMER’S DISEASE AT THE TAU2024 GLOBAL CONFERENCE
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments